XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Note 7 - Employee and Director Benefits
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 7 - EMPLOYEE AND DIRECTOR BENEFITS

 

Stock Incentive Plan

 

The Company has a stock incentive plan as described below. The compensation cost that has been charged to earnings for the plan was approximately $929,000 and $2.7 million for the three and nine months ended September 30, 2023, respectively, and $804,000 and $2.4 million for the three and nine months ended September 30, 2022, respectively.

 

The Company’s 2009 Amended and Restated Stock Incentive Plan authorizes the grant of up to 5,550,000 shares and allows for the issuance of Stock Appreciation Rights, Restricted Stock, Stock Options, Non-stock Share Equivalents, Performance Shares or Performance Units. The plan allows for the grant of incentive stock options and non-qualified stock options, and option awards are granted with an exercise price equal to the fair market value of the Company’s common stock at the date of grant. The maximum term of the options granted under the plan is ten years.

 

There have not been any grants of stock options since October of 2019.

 

The following table summarizes stock option activity during the nine months ended September 30, 2023 and 2022:

 

          

Weighted

     
      

Weighted

  

Average

     
      

Average

  

Remaining

  

Aggregate

 
      

Exercise

  

Contractual

  

Intrinsic

 
  

Shares

  

Price

  

Term (years)

  

Value

 
              

(In Thousands)

 

Nine Months Ended September 30, 2023:

                

Outstanding at January 1, 2023

  280,000  $19.43   3.0  $14,088 

Exercised

  (87,700)  12.04   0.8   3,520 

Forfeited

  (1,000)  34.09   5.3   18 

Outstanding at September 30, 2023

  191,300  $22.65   3.4  $6,235 
                 

Exercisable at September 30, 2023

  139,300  $17.12   1.7  $5,051 
                 

Nine Months Ended September 30, 2022:

                

Outstanding at January 1, 2022

  353,250  $19.28   3.8  $23,525 

Exercised

  (65,500)  16.42   2.3   4,164 
Forfeited  (1,500)  35.21   5.8   67 

Outstanding at September 30, 2022

  286,250  $19.51   3.4  $18,431 
                 

Exercisable at September 30, 2022

  225,500  $14.89   2.3  $14,990 

 

As of September 30, 2023, there was $77,000 of total unrecognized compensation cost related to non-vested stock options. The cost is expected to be recognized on the straight-line method over the next six months.

 

Restricted Stock and Performance Shares

 

The Company periodically grants restricted stock awards that vest upon time-based service conditions. Dividend payments are made during the vesting period. The value of restricted stock is determined to be the current value of the Company’s stock, and this total value will be recognized as compensation expense over the vesting period. As of September 30, 2023, there was $4.6 million of total unrecognized compensation cost related to non-vested time-based restricted stock. The cost is expected to be recognized evenly over the remaining 2.0 years of the restricted stock’s vesting period.

 

The Company periodically grants performance shares that give plan participants the opportunity to earn between 0% and 150% of the number of performance shares granted based on achieving certain market conditions. The number of performance shares earned is determined by reference to the Company’s total shareholder return relative to a peer group of other publicly traded banks and bank holding companies during the performance period. The performance period is generally three years starting on the grant date. The fair value of the performance shares is determined using a Monte Carlo simulation model on the grant date. As of September 30, 2023, there was $895,000 of total unrecognized compensation cost related to non-vested performance shares. As of September 30, 2023, non-vested performance shares had a weighted average remaining time to vest of 1.3 years.

 

  

Restricted Stock

  

Performance Shares

 
  

Shares

  

Weighted Average Grant Date Fair Value

  

Shares

  

Weighted Average Grant Date Fair Value

 

Nine Months Ended September 30, 2023:

                

Non-vested at January 1, 2023

  141,580  $56.39   23,852  $54.16 

Granted

  49,415   60.29   8,091   70.29 

Vested

  (31,492)  52.22   -   - 

Forfeited

  (11,733)  64.78   -   - 

Non-vested at September 30, 2023

  147,770  $57.92   31,943  $58.25 
                 

Nine Months Ended September 30, 2022:

                

Non-vested at January 1, 2022

  127,602  $42.27   12,437  $37.05 

Granted

  52,819   83.33   11,415   72.81 

Vested

  (26,563)  43.51   -   - 

Forfeited

  (8,206)  61.70   -   - 

Non-vested at September 30, 2022

  145,652  $55.84   23,852  $54.16